FOXP3 Monoclonal antibody
FOXP3 Monoclonal Antibody for ELISA
Host / Isotype
Mouse / IgM
Reactivity
human, mouse, rat, monkey
Applications
IF, ELISA
Conjugate
Unconjugated
CloneNo.
7B6A8
Cat no : 60149-1-Ig
Synonyms
Validation Data Gallery
Tested Applications
Recommended dilution
| Application | Dilution |
|---|---|
| Sample-dependent, check data in validation data gallery | |
Published Applications
| IF | See 1 publications below |
Product Information
60149-1-Ig targets FOXP3 in IF, ELISA applications and shows reactivity with human, mouse, rat, monkey samples.
| Tested Reactivity | human, mouse, rat, monkey |
| Cited Reactivity | human |
| Host / Isotype | Mouse / IgM |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen | peptide 相同性解析による交差性が予測される生物種 |
| Full Name | forkhead box P3 |
| Calculated molecular weight | 47 kDa |
| Observed molecular weight | 48 kDa |
| GenBank accession number | NM_014009 |
| Gene symbol | FOXP3 |
| Gene ID (NCBI) | 50943 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Caprylic acid/ammonium sulfate precipitation |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
FOXP3, also named as IPEX, JM2 and Scurfin, is a transcription factor. POXP3 plays a critical role in the control of immune response. Defects in FOXP3 are the cause of immunodeficiency polyendocrinopathy, enteropathy, X-linked syndrome (IPEX)]; also known as X-linked autoimmunity-immunodeficiency syndrome. IPEX is characterized by neonatal onset insulin-dependent diabetes mellitus, infections, secretory diarrhea, trombocytopenia, anemia and eczema. It is usually lethal in infancy. This antibody is a mouse monoclonal antibody raised against a peptide mapping within human FOXP3.
Publications
| Species | Application | Title |
|---|---|---|
Thorac Cancer Potential activity of adiponectin-expressing regulatory T cells against triple-negative breast cancer cells through the cell-in-cell phenomenon |
